The questionnaire asks you about your perceptions of the PDP, with a focus on the guidance made available both by the RCVS and where applicable the resources provided by the BSAVA.
The company stresses that the survey is confidential, and results will be reported in aggregate only; no individual will be identified. It takes 5 minutes and the results will be used to help evaluate and improve the PDP in the future.
Graduates who are currently or have recently completed the PDP are invited to share their views on the PDP: http://app.keysurvey.co.uk/f/1141621/9038/
Employers / mentors of veterinary graduates are invited to share their views on the PDP here: http://app.keysurvey.co.uk/f/1141665/288d/
According to the charity, hens have been badly neglected by the world of evidence-based academic research, with only two known papers written about their welfare.
However, researchers are now starting to take an interest and it is hoped that the new forum, nicknamed The Coop, will pave the way for ground-breaking studies around the world into hen welfare and hen keeping.
Jane Howorth MBE, Founder of the BHWT, said: “The research about to be undertaken ranges from exploring how hens benefit our mental health to seeking good veterinary care and appropriate drugs. They will also examine how the pet hen population has grown over the years and reasons for keeping them, and which homegrown remedies are used and which work.
One of the first bits of research to be supported by the BHWT is a study called ‘From the Backyard to our Beds’ by Jenny Mace BSc, MSc AWSEL, FHEA, Visiting Lecturer on the MSc in Animal Welfare Science, Ethics and Law at the Centre for Animal Welfare at the University of Winchester.
The survey will collect data on the care-taking practices and attitudes towards chickens of non-commercial chicken carers, and you can take part here: https://winchester.onlinesurveys.ac.uk/from-the-backyard-to-our-beds-the-spectrum-of-care-in.
Jenny said: “To my knowledge, this research constitutes the first quantitative study to distinguish between ex-commercial and ‘standard’ chickens. It is also the first to enquire about some niche care-taking practices, such as the use of hormonal implants as a possible means of healthcare in hens.
“The results should be fascinating and I urge all backyard chicken keepers/rescuers to make sure their experiences are captured by filling out this survey. Thank you so much!”
The BHWT is also supporting work undertaken by Keiran Ragoonanan, a student at the Royal Veterinary College in London, who is investigating backyard chicken husbandry and feeding practices in the UK.
For more information visit: https://www.bhwt.org.uk/hen-health/take-part-in-ground-breaking-research-to-help-pet-chickens/
The term ‘evidence synthesis’ describes a range of methodological approaches used to systematically review, appraise, and summarise evidence on a specific area.
The approaches differ from conventional literature reviews or narrative reviews, which are not required to have a specified search strategy or methodology for appraising evidence, and usually present a personal perspective or opinion.
There are three main types of evidence syntheses: rapid reviews, systematic reviews, and scoping reviews.
All have key principles in common, which includes the formulation of a structured question, a systematic search of the available literature, a defined process of reviewing and selecting suitable publications, and a methodology for analysing the final included evidence.
Evidence synthesis is still not widely used in the equine veterinary world, despite its recognised value in human evidence-based medicine.
In the new virtual collection, the EVJ discusses the what and the why of this important evaluation method, as well as providing free access to all the equine veterinary evidence reviews published to date, including:
“Evidence synthesis makes an important contribution towards generating the evidence base which underpins equine clinical practice,” said Professor Sarah Freeman. “The challenge compared to human medicine is that equine veterinary data sets are much smaller, and study approaches and methodologies often vary significantly which means that it may not be possible to combine or collate data sets.
“Given this shortfall, scoping reviews can be helpful to identify what information is out there, find areas where a systematic review could be performed, and provide a useful summary for all the studies in a particular area.”
Professor Celia Marr, Editor of the EVJ said: “As increasing numbers of evidence syntheses are published, they will expand our understanding of the current bodies of evidence in veterinary medicine.
“The existing studies are already informing us on how we use evidence in our practices and policies, and it is encouraging to anticipate how they will shape our development of future research, to generate the best evidence as the norm, in every case.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.evidence-synthesis-collection
Almost all rabies cases are as a result of being bitten by an infected dog, with around half of all dog bites and rabies deaths occurring in children under 15 years of age. Rabies, which is preventable, is categorised as one of the 17 Neglected Tropical Diseases by the World Health Organization (WHO).
The End Rabies Now campaign aims to significantly raise the profile of rabies as a global neglected tropical disease with policy makers and journalists, explaining what is being done to control and eliminate the disease. The campaign is led by Global Alliance for Rabies Control (GARC), and has three key messages:
Ahead of the tenth World Rabies Day, BVA has also recognised vet Professor Sarah Cleaveland OBE for her work in rabies control by awarding her the Chiron Award, one of the Association’s most prestigious awards for outstanding contributions to veterinary science.
Sarah said: "Awards like this are recognition of the contributions not only of one person, but the work of many. We are deeply committed to continuing our efforts towards the global elimination of canine rabies and tackling other zoonotic diseases that affect the health and livelihoods of many of the poorest people in the world."
The End Rabies Now campaign is based around the strong scientific evidence that vaccinating dogs is fundamental to disrupting the cycle of rabies transmission to humans. The target of 2030 was chosen because one of the UN’s sustainable development goals, launched in September 2015, includes the ambition to end by 2030 neglected tropical diseases such as rabies.
With 120 countries still affected by canine rabies, the End Rabies Now campaign advocates that collaborative cross-sector efforts are needed to end zoonotic diseases such as rabies: rabies elimination plans must include human and animal government agencies, veterinary and human health professionals, educators, scientists and community groups.
BVA President Gudrun Ravetz said: "The work being done worldwide by vets, human health professionals and others to combat this horrific disease that senselessly kills thousands each year is of the utmost importance and BVA is proud to support the End Rabies Now campaign and help get those key messages out to policy makers and governments worldwide – every rabies death is entirely preventable and we can end rabies by 2030 through vaccinating dogs."
All entrants to the survey will also be able to enter a draw to win a £50 Amazon voucher.
Jenny Langridge (pictured), Editor of Veterinary Woman, said: “This is our third annual survey and we are seeking the opinions of both Veterinary Woman readers and the wider professions to highlight the key issues affecting women in the veterinary sector.
"We’re not just asking questions, we’re offering veterinary professionals a chance to take part in an ongoing conversation about the very real issues that women face in the veterinary workplace.
"The more diverse the information we can collate about these topics, the more we can work towards achieving changes that help for women to thrive in the professions.”
All data and responses will remain strictly anonymous.
https://bit.ly/vet-woman-readership-survey
A study by Janssen Animal Health has, according to the company, demonstrated that a leading herbal wormer had no demonstrable efficacy against common poultry worms1.
The trial, done to Good Clinical Practice (GCP) Standards, involved 48 chickens that had become naturally infected with three different poultry worms - Capillaria (Hairworm) species, Heterakis gallinarum (Caecal worm) and Ascaridia galii (Large roundworm). The birds were randomly assigned to one of three groups:
A. Flubenvet treated groupB. Herbal wormer treated groupC. Control (untreated) group.
The herbal treatment was administered for 3 days in-feed, as required by the 'on-pack' instructions and Flubenvet was given for 7 days as required on the product data sheet. Droppings were collected from individual birds and group pens at intervals for 2 weeks and examined for the presence of worm eggs
Table 1: Worm Count Summaries
Group
Minimum
Maximum
Median
A (Flubenvet treatment)
0.00
19.00
B (Herbal treatment)
108.00
1327.00
425.00
C (no treatment)
74.00
958.00
302.00
The results showed that very few worm eggs were present after one 7-day treatment with Flubenvet. In contrast, those that had no treatment or the herbal treatment still had hundreds of worm eggs in their droppings, suggesting that there were still many adult egg-laying worms present inside the chickens.
Janssen says poultry keepers who rely on preparations like this particular natural wormer may well be building up problems, as the additional numbers of worm eggs in the environment add to the infection pressure and can result in greater worm burdens for their birds. Birds with high worm burdens are more likely to become ill.
According to the Veterinary Medicines Regulations 2009 any product making veterinary medicinal claims needs to be licensed by the Veterinary Medicines Directorate. A licensed product has to show proven efficacy and safety for the animal species involved. Licensed veterinary medicines can be identified by their Vm number, which is shown on-pack. Products termed 'nutritional supplements', that are not licensed do not require the manufacturer to produce any proof of efficacy or safety. It is often easy to buy such products 'off the shelf' because they are not subject to any controls. Any poultry keeper who cares about the health and welfare of the birds is advised to think carefully about their choice of wormer and to seek advice from a vet pharmacist or Suitably Qualified Person (SQP).
1 Evaluation of the efficacy of flubendazole in comparison with a herbal wormer in the treatment of naturally acquired infections of Ascaridia galli, Heterakis gallinarum, and intestinal Capillaria spp in Chickens, Janssen Animal Health
The EAEVE (European Association of Establishments for Veterinary Education) has granted full accreditation to the Royal Veterinary College.
The RVC is the only one in the world to have achieved full accreditation by EAEVE and the American Veterinary Medical Association (AVMA), and full recognition by the UK's Royal College of Veterinary Surgeons.
Accreditation by EAEVE provides Europe-wide assurance of academic standards. Three other European veterinary schools have achieved accredited status: Copenhagen, Helsinki and Zurich/Bern.
The President of the British Veterinary Association has written to the Badger Trust to clarify the BVA position on the pilot badger culls in England, stating that it will not be supporting the Trust's application for a judicial review.
The BVA Council agreed a position on the continuation of controlled shooting in the pilot areas on 16 April. The position states that the BVA could only support further culling using controlled shooting in the pilot areas if steps are taken to improve both its effectiveness and humaneness and if there is robust monitoring and collation of results and independent analysis and auditing by a non-governmental body. It also states that the BVA supports the Independent Expert Panel's (IEP) recommendations for improving effectiveness and humaneness and urges Defra to implement all the IEP's recommendations fully.
The BVA says that since 16 April, it has been in dialogue with Defra to seek assurances that these issues will be addressed, and those discussions are ongoing. It will not be taking a further position on the pilot culls until BVA Council has had the opportunity to consider Defra's plans in full, when they are made available.
In a press release dated 20th May, The Badger Trust CEO Dominic Dyer said: "It is not acceptable for the DEFRA Secretary of State to now push aside the concerns of both the Independent Expert Panel and the British Veterinary Association, by moving ahead with a further badger cull in Gloucestershire and Somerset this summer without any independent monitoring in place."
The BVA says it is concerned that this misrepresents its position, and has led to some media reports suggesting that the BVA has withdrawn its support for badger culling as part of the overall strategy to eradicate bovine TB. It has not. The BVA says it continues to believe that the TB eradication strategy for England will only be successful if we are able to use all of the available tools, including targeted, humane badger culling.
Participation in this year’s survey was similar to previous years with 5,235 people taking part and returning records for 15,433 horses. Most horses were kept in livery or a private yard and used for leisure and hacking and the majority within the age range of 5 to 10 years.
A broad variety of breeds were represented, including natives, thoroughbred types and warmbloods.
59% of horses were recorded as healthy and 41% with one or more health problems, compared to 62% and 38% respectively in 2016.
The top five disease syndromes recorded this year were:
Of the 5.5% of horses recorded with back problems 26% were also showing signs of lameness. While the details of the results do not confirm that the two are necessarily connected, these findings reflect the outcome of recent studies conducted by Dr Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust.
Sue said: "It is a common observation that horses with lameness stiffen the back as a protective mechanism and develop muscle pain which may be misinterpreted as a primary back problem. We have shown objectively that abolition of lameness by diagnostic analgesia results in an immediate increase in range of motion of the back. The current data supports this close relationship between lameness and back pain."
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
In order to prevent tail injury in one dog you'd need to dock 500, according to research published in this week's Veterinary Record.The study1 was based on 138,212 dogs seen by vets at 52 veterinary practices across Britain between March 2008 and March 2009. 281 were treated for a tail injury - a rate of 0.23%, adjusted for sampling. The owners of 224 of these injured dogs, as well as a random sample of 799 owners whose dogs had not been treated for tail injury were sent a questionnaire on dog tail injuries and docking.Only 97 of the owners whose dogs needed treatment and 227 of those whose dogs had not been injured replied.Their responses indicated that around one in three tail injuries (36%; 35 cases) had occurred at home as a result of the dog knocking its tail against a wall, kennel wall or other household object.A further 17.5% (17 cases) were sustained outdoors, while 14.4% (14 cases) were caused by the tail being caught in a door. In 15 (15.5%) other causes were cited; and in 16 (16.5%), the cause was unknown. Almost half of the injuries (44%) were recurrent.Over half the cases were treated with drugs and dressings, but in almost one in three cases, amputation was required. Eleven dogs did not need any treatment.Certain breeds seemed to be more at risk, with springer and cocker spaniels almost six times as likely to sustain a tail injury as labradors and retrievers. Greyhounds, lurchers, and whippets were almost seven times as likely to do so, possibly because of the lack of protective hair on their tails, say the authors. Dogs with a wide angle of wag were also almost four times as likely to be injured in this way, while dogs kept in kennels were more than 3.5 times as likely to sustain a tail injury. Only 35 owners said their dogs had had their tail docked, and on the basis of their overall findings, the authors calculated that tail docking would reduce the risk of injury by 12%.But in absolute terms, 500 dogs would need to have their tail docked in order to prevent one tail injury.
Reference1Risk factors for tail injuries in dogs in Great Britain. G. Diesel, D. Pfeiffer, S. Crispin, and D. Brodbelt. The Veterinary Record 2010 166: 812-817.
Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.
Bayer Animal Health, maker of Advantage, has produced a new animation to educate pet owners about fleas.
The three minute animation, which is available on YouTube (below), is also available from Bayer for practices to play in the waiting room.
For a copy of the animation, contact your local Bayer Animal Health Territory Manager. More information is also available at http://www.advantagespoton.co.uk/.
Merial has announced the UK launch of updated ProteqFlu, the first and only EI vaccine in Europe to contain a clade 2 strain.
The company says the new vaccine is also the only one that is fully compliant with the latest 2014 OIE recommended EIV strains.
Louise Radford MRCVS from Merial said: "The launch marks the UK's first and only fully updated equine flu vaccine that contains both a Clade 1 and Clade 2 antigen which includes protection against the latest Florida Clade 2 strain, Richmond 07. This is a significant step for horse health, and the equine industry as a whole."
Hervé Poulet, Merial's head of BioDevelopment and BioResearch said: "Merial has developed strong and unique expertise in the development of non-replicative recombinant canarypox virus-vectored vaccines for various species and diseases.
"For the development of ProteqFlu, our non-replicative recombinant canarypox vector expressing the EI virus haemagglutinin (HA) is used because of its ability to induce a strong cellular immunity which is an essential component in protecting against this highly contagious disease."
Louise added: "ProteqFlu has also demonstrated its success and efficacy in real outbreaks, particularly during the last major outbreak, in Australia in 2007. ProteqFlu was the only vaccine chosen for the eradication programme."
Vetsonic has announced the launch of a tablet form of Arthriaid Omega.
Designed to support joint health, the nutraceutical product contains glucosamine, chondroitin, omega 3 fatty acids, MSM, manganese sulphate plus vitamins C and E.
This new tablet form joins the existing range of palatable liquids, chews, cat gel and the original ArthriAid tablets and ArthriAid HA powder, which will continue to be available.
The guidance has been in place since March to help practices continue to provide the public with veterinary services whilst safeguarding the health of their teams and clients.
The RCVS Council Covid-19 Taskforce reviewed the situation on 30th July and decided to extend the guidance after taking into account the pandemic’s progress, the latest government guidance, the headline results from a survey of practice experience of remote consulting, and 'other data from a number of veterinary practices'.
The Taskforce says it also considered the need to continue to provide practices with flexibility in the face of possible local or national lockdowns, the need for inclusivity of those practice teams members and clients who may still be shielding, the likelihood of quarantine of members of the team due to travel and/or Test and Trace and the fact that no major safety issues had been identified as part of the RCVS-commissioned survey into the immediate impact of the temporary guidance.
RCVS President Mandisa Greene, who chairs the Taskforce, said: “Whilst lockdown measures have been eased and matters have improved, we are far from being back to business as usual and the threat of returning to more severe lockdown measures, whether locally or nationally, is still very much alive."
The updated flowchart, along with all the College’s coronavirus guidance for the professions, is available at: www.rcvs.org.uk/coronavirus.
1CPD was launched in 2020 with the aim of providing an easy-to-use platform for veterinary surgeons to use to plan, record and reflect on their continuing professional development (CPD).
The workshops, which are taking place on Wednesday 9th December 2020, are designed to help those who are not yet familiar with the platform, or have some limited experience of it but would like some additional guidance.
The first workshop takes place at midday and is for those members of the profession who haven’t yet used the platform. The session will give an overview of how 1CPD works and the benefits of using it for planning, recording and reflecting on CPD. No prior knowledge is assumed, and complete beginners are especially welcome. There'll be an opportunity to ask questions.
The second workshop takes place at 7pm and is for those who have some experience of using 1CPD but may have further questions, for example, about how to use some of its features such as the planning module and how to best make use of the reflective notes and comments feature.
Both of the workshops will last for approximately an hour each.
Susan Paterson, Chair of the RCVS Education Committee, said: “We’ve seen fantastic take up of the 1CPD platform in less than a year – with around 65% of UK-practising veterinary surgeons and an amazing 80% of veterinary nurses using it to plan, record and reflect on their professional development. The feedback that we receive has been overwhelmingly positive, with the even the more technically-challenged amongst us finding 1CPD intuitive.
"Although the numbers are very encouraging, there is a cohort of people who have not yet actively engaged with the platform and maybe are unsure about using it or are put off by the thought of having to learn how to use a brand new online system. The aim of these workshops is to guide and reassure those who are hesitant that the 1CPD system is very simple and easy-to-use with lots of useful features. In the long run, it will save you a lot of time and effort when it comes to recording your CPD because it’s there on your phone or tablet, ready to update as-and-when you need to."
Richard Burley, Chief Technology Officer for the RCVS, added: “We are very glad that the 1CPD platform developed by our team here has been so well received. We are continuing to improve and update the platform based on user feedback to improve its design and usability and would welcome any further constructive comments that members of the professions have about it. We do hope you those who are both unfamiliar with the system, and those who have used it but need further advice, can join us for these sessions to find out both how to use 1CPD and how to get the best out of it.”
To sign up to one of the workshops, visit: www.rcvs.org.uk/news-and-views/events/1cpd-online-workshop.
For those who aren’t able to make it on the day, recorded versions of all of the workshops will be made available to watch again after the event.
To download 1CPD as an app for use on iOS (Apple) or Android devices, or to access the web version, visit: www.rcvs.org.uk/1CPD
The BSAVA has launched the BSAVA Manual of Canine and Feline Radiography and Radiology with a new introductory text aimed at veterinary students, nurses and new graduates.
The Association says confident radiographic interpretation presents a considerable challenge and the BSAVA Manual of Canine and Feline Radiography and Radiology provides a comprehensive review of the approach to radiological interpretation, the range of variants and the key fundamental principles and their application to common diseases.
The manual features high quality radiographic reproductions demonstrating normal anatomy and key aspects of interpretation, as well as illustrations showing patient positioning and the practical approach that is the hallmark of the BSAVA manuals.
The book contains the following contents:
An extra feature is the CD, which contains all the radiographic images from the manual, so that readers can view the many images at an enlarged size.
The manual is available from October and can be ordered from www.bsava.com.
Invicta Animal Health has launched an enhanced version of the ChroMyco Duo dermatophyte test.
The tests use a new round plate with an improved lid design. In addition, the plates are wider and deeper providing 25% more culture medium.
According to the company, the dual plate test with Dermatophyte Test Media (DTM) on one side and an Enhanced Sporulation Agar (ESA) on the other greatly reduces the risk of false positive results.
The test is performed by veterinary staff taking a pluck of fur or skin scrape from the lesion and inoculating both sides. After three to six days of room temperature incubation, if dermatophytes are present, the DTM will turn red and the ESA will turn blue-green.
Rob Watkins, Managing Director of Invicta, said: "We always listen and respond to customer feedback. The new design plates provide reduced condensation levels and by being easier to inoculate will enhance the usability and hence reliability of the test."
The price remains unchanged at £32.00 for 5 tests, from veterinary wholesalers.
For more information call 01403 791313 or email mail@invictavet.com.
The campaign will highlight things that can be done to help anxious pets, including getting professional advice from a behaviourist or trainer and using the company's products.
There's a marketing pack for practices, to help you educate owners and promote the month. It includes bunting, wall displays, posters, leaflets and gift vouchers for pet owners.
To raise awareness, Ceva will also be running a PR and advertising campaign together with a social media initiative in which owners will be encouraged to share their experience of having an anxious pet on Instagram and Facebook.
Abigail King, senior product manager at Ceva said: "It is widely known that humans suffer from anxieties, but pets do too with 82% of dogs and 89% of cats reported to be scared of something1.
"It is therefore important that we educate pet owners on the signs of stress and the help and support that they can give to their pets.
"Pet Anxiety Month will get people talking and we want people to know that there are products out there to support pets and that help is at hand to get the right advice, which is extremely important."
For further information, visit the Pet Anxiety Month website or follow the campaign on Instagram and Facebook. To request the Pet Anxiety Month marketing pack, email cevauk@ceva.com.
Reference
The company's Postgraduate Certificate (PgC) programme in Dentistry and Oral Surgery - delivered and awarded in partnership with Harper Adams University (HAU) and the International School of Veterinary Studies (ISVPS) - has been added to the list of qualifications conferring eligibility for applications for the AP Status in Small Animal Dentistry.
In addition, Improve's Postgraduate Diploma (PgD) in Advanced Veterinary Practice Sciences, achieved by obtaining the PgC in Small Animal Surgery, plus the ISVPS General Practitioner Advanced Certificate (GPAdvCert) in Small Animal Orthopaedic Surgery (together with two further modules with HAU), has also been recognised as an eligible entry qualification for application for the RCVS’ AP status in Small Animal Orthopaedics.
The GPAdvCert programme in Orthopaedic Surgery is due to start in September 2020 with the PgC programme in Dentistry and Oral Surgery commencing in January 2021.
Improve says that depending on the situation with coronavirus at the time, it will provide appropriate personal protective equipment for attending delegates and arrange for live sessions to be streamed online if physical attendance is not possible. Practical sessions will be rescheduled for the earliest possible date and the company has also revised its terms and conditions to provide maximum flexibility to delegates in case their circumstances change.
Photo: David Babington, Business Development Director, Improve International
The Walpole Bay Tidal Pool is the biggest in the UK, covering four acres.
Everyone taking part is being challenged to raise at least £100 for Vetlife, to go towards its helpline, health support and financial support for the veterinary community.
Sea temperature at this time of year is a decidedly brisk 10 degrees Celsius, but Vetlife says the dress code is reasonably relaxed: anything from a swimming costume to a full diving dry suit!
https://events.more-human.co.uk/event/1713190086537x259173669533122560
The survey, which takes about three minutes, will assess horse owners’ experiences of strangles and includes questions on the disease including preventative measures and vaccination.
There will be a prize draw from completed entries and the winner will get two VIP tickets to Your Horse Live 2025.
Rachel Harrison-Osborne MRCVS, equine field manager at Dechra said: “The strangles survey will provide us with a valuable insight into horse owners’ experiences of the disease and will enable us to identify any trends that may exist to help us support owners who wish to put in place preventative measures to help prevent strangles.”
https://forms.office.com/e/85gzEd7J7A
Photo: Redwings Horse Sanctuary
The World Organisation for Animal Health (OIE) and the Food and Agriculture Organisation of the United Nations (FAO) have announced that today marks the declaration of the eradication of rinderpest, one of the world's most dreaded animal diseases.
The BVA likened this announcement in the history of animal health to that of the eradication of smallpox in humans.
The announcement came during the 79th General Session of the World Organisation for Animal Health (OIE), held in Paris. The global freedom status will be ratified by Ministers of Agriculture at the Food and Agriculture Organization of the United Nations (FAO) conference in June.
Rinderpest, also known as cattle plague, has ravaged cattle and the human populations that depend on them throughout history. It was rinderpest that led to the formation of the OIE in 1924 following a new incursion of the rinderpest virus in Europe, via the port of Antwerp.
Dr Peter Roeder, who was Secretary of the Global Rinderpest Eradication Programme from 2000 to 2007, said: "Once a dream, rinderpest eradication is now a reality. Not only does this magnificent achievement help to protect the livelihoods of many millions of livestock-dependent farmers but, because it removes a serious constraint to livestock trade, it has a major positive impact on many countries' economies. If we can truly learn the lessons from rinderpest eradication there is no reason why we couldn't see other diseases brought to global extinction with similar pro-poor and economic impact."
BVA President Harvey Locke added: "This monumental achievement testifies to the dedication of the veterinary services of affected countries and illustrates how vets and veterinary science can have a global impact. With that in mind I am absolutely delighted that Dr Roeder will be presenting the plenary Wooldridge Memorial Lecture at this year's BVA Annual Congress. Entitled 'Making a global Impact' Dr Roeder will discuss how vets can contribute to disease control on a global scale.
"I should also like to pay tribute to two British veterinary surgeons who made seminal contributions to the global effort to eradicate rinderpest. Gordon Scott, a rinderpest researcher, and Walter Plowright who developed the tissue culture rinderpest vaccine, were both leading lights of the rinderpest eradication effort. Sadly they are no longer with us to witness this milestone in veterinary history."
As part of the BVA's celebration of World Veterinary Year Vet2011 and to further illustrate how vets and veterinary science can have a global impact the Overseas Group is organising on Friday 23 September a full day's programme at BVA Congress: exploring current issues concerning livestock and global food security, veterinary involvement in disaster relief and management, as well as a session celebrating 100 BVA overseas travel grants.
Photograph: Rinderpest virus, copyright held by dr. Rajnish Kaushik